Related Experiment Video
Updated: Nov 21, 2025
05:35
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
1.1K
Pregnancy-associated aplastic anemia: a case-based review.
José Carlos Jaime-Pérez1, Mariana González-Treviño1, David Gómez-Almaguer1
1Department of Hematology, Internal Medicine Division, Dr. Jos Eleuterio González University Hospital and School of Medicine, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
Expert Review of Hematology
|January 12, 2021
Summary
Pregnancy-associated aplastic anemia (pAA) is a rare condition where aplastic anemia is diagnosed during pregnancy. Early diagnosis and multidisciplinary care are crucial for improving maternal and fetal outcomes in pAA.
Area of Science:
- Hematology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Pregnancy-associated aplastic anemia (pAA) is a rare but severe condition.
- It presents unique diagnostic and management challenges due to physiological changes in pregnancy.
- The etiologic relationship between pregnancy and bone marrow failure in pAA remains unclear.
Observation:
- This review presents three new cases of pAA and discusses its controversial relationship with pregnancy.
- A literature review identified 54 reported cases of pAA between 1975 and 2020.
- The atypical presentation and management of pAA were analyzed.
Findings:
- The diagnosis of pAA is challenging due to pregnancy-induced hematological alterations that can mask the condition.
- Meticulous monitoring and supportive therapy are essential for managing pAA.
- Multidisciplinary team involvement is key to improving outcomes.
Implications:
- Frequent assessments during pregnancy and postpartum are vital for optimal patient care.
- Prompt and definitive treatment strategies should be considered for women diagnosed with pAA.
- Improved understanding and management protocols can enhance maternal and neonatal survival rates in pAA.
Related Concept Videos
01:15Transcytosis of IgG
3.8K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.8K
01:22iPS Cell Differentiation
2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
01:07Teratogenicity
3.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.7K